AI Summary
✦ ClarthaValuation Metrics
Trading 27.5% below historical median. Valuation is declining — currently in the strongly undervalued zone (z-score: -1.12). Confidence: 71%.
Live forward EPS implies next-12-month EPS of ₹10.30. Applying the stock's normalized valuation corridor produces a fair range of ₹207.03 to ₹324.04, with base value near ₹259.25 (+127.4% vs current price).
Live forward estimate anchored to the company's historical valuation corridor.
Forward EPS
₹10.30
Forward P/E
11.1x
Base Fair Value
₹259.25
Fair Range
₹207.03 - ₹324.04
Upside To Base
+127.4%
Estimate Source
Live forward EPS
Growth Estimate
-4.8%
5Y Average
22.80
Current
18.24
Overvalued
31.46
Undervalued
20.10
5Y Average
0.80
Current
0.64
Overvalued
0.92
Undervalued
0.68
5Y Average
13.38
Current
10.71
Overvalued
16.69
Undervalued
10.31
Peers & Comparison
Sector: Health Care · Theme: Hospitals & Diagnostic Centres
| Company | Rev. Growth | Margin | P/E | vs Avg | 52W Perf. |
|---|---|---|---|---|---|
GPT HEALTHCARE LIMITED GPTHEALTHHospitals & Diagnostic Centres | +17.8% | 9.6% | 27.0x Undervalued | -59% vs avg | -0.2% |
GUJARAT KIDNEY N SUP SP L GKSLHospitals & Diagnostic Centres | +212.6% | 18.9% | 54.9x Undervalued | -16% vs avg | +27.4% |
NARAYANA HRUDAYALAYA LTD. NHHospitals & Diagnostic Centres | +80.4% | 9.0% | 45.2x Undervalued | -31% vs avg | +1.0% |
ASTER DM QUALITY CARE LTD ASTERDMHospitals & Diagnostic Centres | +21.6% | 6.5% | 138.4x Premium | +111% vs avg | +39.5% |
FORTIS HEALTHCARE LTD FORTISHospitals & Diagnostic Centres | +17.5% | 11.0% | 67.9x Fair | +4% vs avg | -3.4% |
GLOBAL HEALTH LIMITED MEDANTAHospitals & Diagnostic Centres | +26.5% | 11.9% | 71.0x Fair | +8% vs avg | +6.3% |
JUPITER LIFE LINE HOSP L JLHLHospitals & Diagnostic Centres | +18.2% | 12.0% | 54.7x Undervalued | -16% vs avg | +9.7% |
APOLLO HOSPITALS ENTER. L APOLLOHOSPHospitals & Diagnostic Centres | +18.1% | 7.7% | 65.3x Fair | 0% vs avg | +12.1% |
Comparable-scale peer data is limited — showing nearest stored business/industry peers instead of an empty comparison.
Financials
Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.
Latest revenue
₹91 CrJun 2026Latest net profit
₹6.64 CrJun 2026Latest EPS
₹1.17Jun 2026Net margin
15.1%Jun 2026Performance
Bars show revenue and net profit. The line shows net margin.
- Revenue
- Net income
- Net margin %
Earnings
Revenue is shown in crores. EPS is rupees per share.
- Revenue
- EPS
Revenue to profit conversion
Bridge from operating numbers to profit for the latest reported period.
Latest reported period: Jun 2026
Debt level and coverage
Debt, cash and free cash flow compared on the same crore scale.
- Debt
- Free cash flow
- Cash & equivalents
Results
| Metric | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 66.36 | 68.33 | 69.08 | 82.87 | 74.95 | 91.07 | 100.19 | 99.94 | 95.46 | 100.58 | 94.78 | 96.99 | 91.33 |
| Expenses + | 58.20 | 57.42 | 57.70 | 70.35 | 66.22 | 80.83 | 89.80 | 113.66 | 86.69 | 91.43 | 82.57 | 123.72 | 77.54 |
| Operating Profit | 8.16 | 10.91 | 11.38 | 12.52 | 8.73 | 10.24 | 10.39 | -13.72 | 8.77 | 9.15 | 12.21 | -26.73 | 13.79 |
| OPM % | 12.30% | 15.97% | 16.47% | 15.11% | 11.65% | 11.24% | 10.37% | -13.73% | 9.19% | 9.10% | 12.88% | -27.56% | 15.10% |
| Other Income + | 0.15 | 0.30 | 0.57 | 0.22 | 0.23 | 1.75 | 0.59 | 35.87 | 1.59 | 5.00 | 2.07 | 4.71 | 1.53 |
| Interest | 1.22 | 1.07 | 1.27 | 1.41 | 1.17 | 1.61 | 1.90 | 1.66 | 2.07 | 2.61 | 2.45 | 3.13 | 3.10 |
| Depreciation | 2.14 | 2.20 | 2.15 | 2.00 | 2.66 | 2.85 | 2.87 | 9.61 | 2.81 | 2.81 | 2.81 | 2.97 | 2.90 |
| Profit before tax | 4.95 | 7.94 | 8.53 | 9.33 | 5.13 | 7.53 | 6.21 | 10.88 | 5.48 | 8.73 | 9.02 | -28.12 | 9.32 |
| Tax % | 26.87% | 29.47% | 27.78% | 27.01% | 32.55% | 24.83% | 4.35% | 139.61% | -45.99% | 28.87% | 56.98% | -32.75% | 28.76% |
| Net Profit + | 3.62 | 5.60 | 6.16 | 6.81 | 3.46 | 5.66 | 5.94 | -4.31 | 8.00 | 6.21 | 3.88 | -18.91 | 6.64 |
| EPS in Rs | 0.66 | 1.02 | 1.12 | 1.23 | 0.62 | 1.01 | 1.06 | -0.76 | 1.42 | 1.10 | 0.69 | -3.35 | 1.17 |
| Raw PDF | |||||||||||||
| YOY Sales Growth % | 47.11% | 39.73% | 36.41% | 26.25% | 12.94% | 33.28% | 45.03% | 20.60% | 27.36% | 10.44% | -5.40% | -2.95% | -4.33% |
| Material Cost % | 46.46% | 43.11% | 40.46% | 50.75% | 50.53% | 54.08% | 50.22% | 39.72% | 52.66% | 48.54% | 31.65% | 51.17% | 39.09% |
| Employee Cost % | 32.97% | 31.83% | 34.22% | 27.95% | 31.19% | 27.18% | 27.27% | 28.68% | 29.83% | 30.13% | 33.64% | 28.34% | 36.69% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -1.30 | 0.00 | 0.00 |
| Other income normal | 0.15 | 0.30 | 0.57 | 0.22 | 0.23 | 1.75 | 0.59 | 35.87 | 1.59 | 5.00 | 3.37 | 4.71 | 1.53 |
| Exceptional items AT | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.06 | 0.00 | 0.00 |
| Profit excl Excep | 3.62 | 5.60 | 6.16 | 6.81 | 3.46 | 5.66 | 5.94 | -4.31 | 8.00 | 6.21 | 3.82 | -18.91 | 6.64 |
| Profit for PE | 3.62 | 5.60 | 6.16 | 6.81 | 3.46 | 5.66 | 5.94 | -4.31 | 8.00 | 6.21 | 3.82 | -18.91 | 6.64 |
| Profit for EPS | 3.62 | 5.60 | 6.16 | 6.81 | 3.46 | 5.66 | 5.94 | -4.31 | 8.00 | 6.21 | 3.88 | -18.91 | 6.64 |
| YOY Profit Growth % | 49.59% | 71.25% | 115.38% | 773.08% | -4.42% | 1.07% | -3.57% | -163.29% | 131.21% | 9.72% | -35.69% | -338.75% | -17.00% |
All values in ₹ Crores unless otherwise stated. Source: Screener Master (Standalone).
Events Timeline
Notice Of The 32Nd Annual General Meeting Of The Company To Be Held On Tuesday, September 01, 2026